Natural Protein Points to New Inflammation Treatment Findings may offer insight to effective treatments for inflammatory diseases, such as rheumatoid arthritis, psoriasis, and multiple sclerosis.Tricked-Out Immune Cells Could Attack Cancer New cell-engineering technique may lead to precision immunotherapies.Therapy Halts Progression of Lou Gehrig’s Disease Researchers at Oregon State University announced today that they have essentially stopped the progression of amyotrophic lateral sclerosis (ALS), or Lou Gehrig’s disease, for nearly two years in one type of mouse model used to study the disease – allowing the mice to approach their normal lifespan.Crouching Protein, Hidden Enzyme A new study led by scientists at The Scripps Research Institute (TSRI) and the University of California (UC), Berkeley shows how a crucial molecular enzyme starts in a tucked-in somersault position and flips out when it encounters the right target.Utilizing Antibodies from Ebola Survivors A collaborative team from The University of Texas Medical Branch at Galveston, Vanderbilt University, The Scripps Research Institute and Integral Molecular Inc. have learned that antibodies in the blood of people who have survived a strain of the Ebola virus can kill various types of Ebola.Engineering Foe into Friend Bose Grant awardee Jacquin Niles aims to repurpose the malaria parasite for drug delivery.Important Regulator of Immune System Decoded Plasma cells play a key role in our immune system. Now scientists at the Research Institute of Molecular Pathology (IMP) in Vienna, Austria, and at the Walter and Eliza Hall Institute (WEHI) in Melbourne, Australia, succeeded in characterizing a central regulator of plasma cell function.Bacterial Superglue for Faster Vaccine Development An interdisciplinary team of Oxford University researchers has devised a new technique to speed up the development of novel vaccines.Enumeral, MD Anderson Enter Into Collaboration Strategic collaboration aims to discover and develop potentially novel antibodies against specified targets for immunotherapy.Joint venture for GlycoMar Limited and MicroA AS Scottish biotechnology company GlycoMar and Norwegian technology company MicroA are pleased to announce their joint venture business Prasinotech Ltd. The new company is registered in Scotland.
A Potentially Scalable Method for the Harvesting of hMSCs from Microcarriers: Initial Results Qasim Rafiq, Loughbrough University, speaking at Advances in Cellular Assays & Cell Culture 2014
Magneto-plasmonic Nanoparticle Platform for Capture, Separation and Enumeration of Rare Cells Konstantin Sokolov, The University of Texas at Austin, speaking at Nanomedicine 2014.
Your body is 3D, why is your cell culture not? Christian Oberdanner, PhD, Application Specialist Sales & Marketing, Tecan Austria GmbH
Library Design for Tackling Protein-protein Interactions: The 2P2I Approach Dr Philippe Roche, CNRS, speaking at Discovery Chemistry Congress 2013.
PASylation: the Biological Alternative to PEGylation Uli Binder, XL Protein GmbH, speaking at Discovery Chemistry Congress 2013.
SUT Applications in Up – and Downstream Bioprocessing Professor Manuel Carrondo, University Nova de Lisboa, speaking at Stem Cells & Bioprocessing Europe 2012.
Plasma Treatment at Atmospheric Pressure – a Versatile Tool to Modify Substrates with Complex Geometries Dr Kristina Lachmann, Fraunhofer Institute for Surface Engineering and Thin Films, speaking at Stem Cells & Bioprocessing Europe 2012.
An ACE Method for Monitoring Protein-protein Interactions (PPIs) Carol Austin, Selcia, speaking at Discovery Chemistry Congress 2013.
Characterisation of an Automated Micro Bioreactor With CHO Cultures: Process Control, Clone Ranking, Process Optimisation and DoE Barney Zoro, TAP Biosystems, speaking at Stem Cells & Bioprocessing Europe 2012.
Public Funding for Academic Bioprocessing Research in the UK Ben Sykes, BBSRC, speaking at Stem Cells & Bioprocessing Europe 2012.